Author

Patrick Reichenbach

Centre Hospitalier Universitaire VaudoisORCID 0009-0000-8673-1936Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:protein design· 1

Frequent Co-Authors

Elisabetta CribioliiD· 2 shared Greta Maria Paola Giordano AttianeseiD· 2 shared Melita B. IrvingiD· 2 shared Morteza HafeziiD· 2 shared Anthony MarchandiD· 1 shared Benita WolfiD· 1 shared Bernhard GentneriD· 1 shared Bruno E. CorreiaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Elisabetta CribioliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Synthetic BiologyNature Chemical BiologyPeer-reviewedFeb 19, 2026

Drug-controlled CAR-T cells through the regulation of cell-cell interactions

Leo Scheller, Greta Maria Paola Giordano Attianese, Rocío Castellanos-Rueda…·Melita B. Irving

This paper develops DROP-CARs, drug-regulated CAR-T cells that control cell-cell interactions using small-molecule switches, showing in vitro and in vivo functionality.

2 citationstop 5%

humanexperimental assay

𝕏 PostBluesky

BioengineeringCytotherapyPeer-reviewedFeb 10, 2025

DNA-Dependent Protein Kinase Inhibitors PI-103 and Samotolisib Augment CRISPR/Cas9 Knockin Efficiency in Human T Cells

Emina Džafo, Morteza Hafezi, Greta Maria Paola Giordano Attianese…·Bernhard Gentner

This study shows that PI-103 and samotolisib enhance CRISPR/Cas9-mediated TCR knockin efficiency in human T cells without affecting viability or phenotype.

2 citations

humanexperimental assay

𝕏 PostBluesky